Old Republic International Corp (ORI) · Oct 22, 2026 · Earnings
Miss — Diluted operating EPS $0.73 vs ~$0.79 consensus
Old Republic’s Q3 earnings miss on core operating EPS as specialty underwriting deteriorates, while title insurance posts a meaningful profit recovery.
Old Republic is building a diversified specialty-insurance platform while trying to restore Title Insurance profitability; the July 1 ECM acquisition adds a niche farmowners and commercial-agriculture business to that specialty strategy.
The quarter missed on the operating metric that matters most. Diluted net operating income was $0.73 versus $0.78 a year ago, below the published consensus of roughly $0.79, while operating revenue rose 8.0% to $2.51 billion versus roughly $2.49 billion expected. The headline $0.99 diluted EPS was flattered by a $0.51-per-share bargain-purchase gain and partly offset by $0.25 per share of investment losses, so it overstates the underlying quarter.
| Metric | Q3 2026 | Q3 2025 / expectation | Read |
|---|---|---|---|
| Diluted net operating income per share | $0.73 (Financial Highlights) | $0.78 prior year; ~$0.79 consensus | Miss |
| Net premiums and fees earned | $2,269.3 million (Summary Income Statements) | $2,086.2 million prior year | Up 8.8% |
| Net operating income | $181.4 million (Overall Results) | $196.7 million prior year | Down 7.8% |
| Consolidated combined ratio | 96.1% (Overall Results) | 95.3% prior year | Worse by 0.8 points |
| Title Insurance pretax operating income | $50.4 million (Sources of Consolidated Income) | $45.7 million prior year | Up 10.1% |
| Specialty Insurance pretax operating income | $203.9 million (Sources of Consolidated Income) | $207.7 million prior year | Down 1.8% |
Specialty Insurance is the main weakness beneath the growth headline. Premiums grew, but underwriting income fell 15.4% to $58.5 million and the segment combined ratio worsened to 96.0% from 94.8%. The deterioration reflects less favorable prior-year reserve development, higher expenses tied to start-ups, technology modernization, data and analytics, and artificial-intelligence investments, plus ongoing pressure from lines such as trucking. Excluding the auto-warranty pricing presentation, premium growth was a more modest 7.1% for the quarter.
Title Insurance provides the genuine offset. Its pretax operating income rose 10.1% to $50.4 million, while the combined ratio improved to 96.1% from 96.4%. That is progress from the difficult real-estate environment, but it remains above management’s 90%–95% full-cycle target, so the recovery is underway rather than complete. 〔0〕
The ECM contribution is real but not a surprise. The acquisition closed as previously expected and delivered a $124.9 million bargain-purchase gain; management had already disclosed that a gain of approximately $125 million and 2026 earnings accretion were expected. That makes the accounting gain largely known, while the more important new information is whether ECM can help broaden specialty growth without adding to the expense burden.
Capital returns remain substantial, but they do not erase weaker operations. Old Republic returned $190.2 million during the quarter through dividends and repurchases, while shareholders’ equity per share still edged up 1.8% from year-end to $24.65. The capital-return message is steady, but the quarter’s operating earnings declined and the combined ratio moved further away from the specialty target range.
Bottom line: This was a revenue-growth quarter, not an earnings-quality win. Title Insurance improved and ECM is contributing, but weaker specialty underwriting left core operating EPS below expectations and makes the overall read a miss.
Q3 earnings call, October 22 at 3 p.m. ET
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!